Subscription Required

Only paid subscribers* to Drug Benefit News can access this Web portal with three years of back issues, searchable article archives and other valuable resources.

Subscribers to Drug Benefit News receive

  • 24 biweekly issues of timely news and insightful strategies for reducing costs and improving outcomes, delivered by First Class U.S. Mail and electronically,
  • E-News Alerts whenever important news breaks, and
  • Access to a subscriber-only Web page with:
    • Searchable archives of past articles,
    • Convenient library with PDFs of back issues,
    • Recent stories of interest and hot topic articles grouped for convenient reading, and
    • Regular postings from your editor.
View a sample and get more information
November 18, 2016

Recent Stories

From Drug Benefit News - Differences in medication adherence measures did have an effect on CMS’s 2017 star quality ratings as part of an interim adjustment used to address socioeconomic status (SES) in the star quality ratings program. But the overall effect of the SES adjustment was quite small, affecting only a handful of Medicare Part D plans, according to an analysis from Inovalon Inc. Read more

With Republican Donald Trump being declared the next U.S. president and the… Read more

A recent agreement between the New York attorney general and a major… Read more

Plan sponsors are focusing hard on specialty pharmacy costs for 2017, looking… Read more

From the Editor

Welcome to your Drug Benefit News subscriber-only Web page

Be sure to visit often, for PDFs of issues, archives of articles and data, and more!

Please e-mail me with comments on the last issue of Drug Benefit News, story ideas for future issues or any other suggestions you have that can make the newsletter more useful for you.

December 2, 2016
CMS Releases 2015 National Health Expenditures Data

CMS reports that spending on prescription drugs rose 9.0% in 2015, down from 12.4% growth in 2014 but an increase from 2.3% in 2013

October 17, 2016
Biden Delivers Moonshot Report

Vice President Biden issues final Cancer Moonshot report to president, will address public this afternoon

August 29, 2016
Walgreens, Prime Therapeutics Partner on Specialty and Mail-Order Business

Walgreens, Prime Therapeutics partner on specialty and mail-order business.

Updated Regularly

Featured Hot Topics

Search for your own Hot Topics

It's quick and easy to sign up for FREE access to!

Why do I need to register?